AT1 4.76% 2.2¢ atomo diagnostics limited

Ann: Atomo & Access Bio sign deal for rapid antigen test, page-74

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    This is interesting...and a v positive story for the Access Bio's nasal Ag RDT product.
    https://cbs4local.com/news/local/access-bio-covid-testing-trial-tests-kids-in-las-cruces

    Seems AccBio is conducting further trials for its Ag RDT in the US - for people, even kids, to self-test themselves.

    Short video worth watching and it appears that AccBio has been adapting the nasal swab lengths + kit for children's noses.

    Las Cruces is the second-largest city in the US state of New Mexico. As per article, this is one of the trial locations...so guess must be doing this in other US cities too? Will be a good win, especially if they can demonstrate that even un-trained children can do a self-nasal Ag test successfully. Especially since everyone who has had nasal swabs says its quite uncomfortable.

    This will allow AccBio + AT1 to sell the self-test/no-professional-needed version, especially in markets where it is allowed by regulatory authorities.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $14.06M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $4.382K 199.2K

Buyers (Bids)

No. Vol. Price($)
1 523 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 224370 5
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.